MedTrace Logo

Prostate Cancer Utilities and Cost-Effectiveness Analysis

NCT00203918 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 481

Last updated 2017-08-30

No results posted yet for this study

Summary

The purpose of this study is to help doctors and patients make better decisions about prostate cancer treatment. This research is being done because we do not know how patient preferences for health states related to prostate cancer affect the final treatment decision.

Conditions

Interventions

BEHAVIORAL

Survey, interview

A survey is administered to patients visiting the urology clinic to undergo prostate biopsies to validate a method of utility assessment, and understand patients' individual evaluations of treatment-related health states. Medical records will also be reviewed 00 days after the survey was administered to determine whether this data reflects actual treatment decisions.

BEHAVIORAL

patient utility scores (i.e. patient preference weights)

comparison of patient preferences

Sponsors & Collaborators

  • University of Chicago

    lead OTHER

Principal Investigators

  • David Meltzer, M.D., Ph.D. · University of Chicago

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-31
Primary Completion
2011-02-28
Completion
2013-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00203918 on ClinicalTrials.gov